FI874596L - Peptidpreparat. - Google Patents

Peptidpreparat. Download PDF

Info

Publication number: FI874596L
Authority: FI; Finland
Prior art keywords: peptide preparations; preparations; peptide
Prior art date: 1986-10-20

Application number

FI874596A

Other languages

English (en)

Other versions

FI86254C (fi

FI86254B (fi

FI874596A0 (fi

Inventor

Klavs Holger Joergensen

Original Assignee

Novo Industri As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-20

Filing date

1987-10-19

Publication date

1988-04-21

1986-10-20 Priority claimed from DK503386A external-priority patent/DK503386D0/da

1987-07-10 Priority claimed from DK356987A external-priority patent/DK356987D0/da

1987-10-19 Application filed by Novo Industri As filed Critical Novo Industri As

1987-10-19 Publication of FI874596A0 publication Critical patent/FI874596A0/fi

1988-04-21 Publication of FI874596L publication Critical patent/FI874596L/fi

1992-04-30 Application granted granted Critical

1992-04-30 Publication of FI86254B publication Critical patent/FI86254B/fi

1992-08-10 Publication of FI86254C publication Critical patent/FI86254C/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

FI874596A 1986-10-20 1987-10-19 Foerfarande foer framstaellning av insulinpreparat. FI86254C (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK503386A DK503386D0 (da)	1986-10-20	1986-10-20	Peptidpraeparater
DK503386		1986-10-20
DK356987A DK356987D0 (fi)	1987-07-10	1987-07-10
DK356987		1987-07-10

Publications (4)

Publication Number	Publication Date
FI874596A0 FI874596A0 (fi)	1987-10-19
FI874596L true FI874596L (fi)	1988-04-21
FI86254B FI86254B (fi)	1992-04-30
FI86254C FI86254C (fi)	1992-08-10

Family

ID=26067111

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI874596A FI86254C (fi)	1986-10-20	1987-10-19	Foerfarande foer framstaellning av insulinpreparat.

Country Status (18)

Country	Link
US (1)	US5070186A (fi)
EP (1)	EP0265213B1 (fi)
KR (1)	KR880004819A (fi)
CN (1)	CN87107049A (fi)
AU (1)	AU616381B2 (fi)
CA (1)	CA1316819C (fi)
DE (1)	DE3778287D1 (fi)
ES (1)	ES2033871T3 (fi)
FI (1)	FI86254C (fi)
GR (1)	GR3004912T3 (fi)
HU (1)	HU201475B (fi)
IE (1)	IE60264B1 (fi)
IL (1)	IL84203A (fi)
NO (1)	NO170754C (fi)
NZ (1)	NZ222214A (fi)
PH (1)	PH23446A (fi)
PT (1)	PT85949B (fi)
YU (1)	YU46665B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5534488A (en) *	1993-08-13	1996-07-09	Eli Lilly And Company	Insulin formulation
AR002976A1 (es) *	1995-03-31	1998-05-27	Lilly Co Eli	Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
EP1044016B1 (en) *	1998-01-09	2005-03-16	Novo Nordisk A/S	Stabilised insulin compositions
US7678364B2 (en)	1999-08-25	2010-03-16	Alkermes, Inc.	Particles for inhalation having sustained release properties
DE10114178A1 (de) *	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
US20030078195A1 (en) *	2001-08-27	2003-04-24	Kristensen Lars Thougaard	Cartridge and medical delivery system accommodating such cartridge
BR0317896A (pt) *	2002-12-31	2005-12-06	Altus Pharmaceuticals Inc	Complexos de cristais de proteìna e polìmeros iÈnicos
SG176314A1 (en) *	2002-12-31	2011-12-29	Altus Pharmaceuticals Inc	Human growth hormone crystals and methods for preparing them
US20090023629A1 (en) *	2005-12-23	2009-01-22	Altus Pharmaceuticals Inc.	Compositions comprising polycation-complexed protein crystals and methods of treatment using them
CN101573133B (zh)	2006-07-31	2014-08-27	诺沃-诺迪斯克有限公司	Peg化延长的胰岛素
PL2074141T3 (pl)	2006-09-22	2017-02-28	Novo Nordisk A/S	Analogi insuliny oporne na proteazę
WO2008132229A2 (en) *	2007-04-30	2008-11-06	Novo Nordisk A/S	Highly concentrated insulin solutions and compositions
JP5496082B2 (ja)	2007-04-30	2014-05-21	ノボ・ノルデイスク・エー／エス	タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
WO2009112583A2 (en)	2008-03-14	2009-09-17	Novo Nordisk A/S	Protease-stabilized insulin analogues
JP5749155B2 (ja)	2008-03-18	2015-07-15	ノボ・ノルデイスク・エー／エス	プロテアーゼ安定化アシル化インスリンアナログ
LT2349324T (lt)	2008-10-17	2017-12-27	Sanofi-Aventis Deutschland Gmbh	Insulino ir glp-1 agonisto derinys
JP5832439B2 (ja)	2009-11-13	2015-12-16	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	Ｇｌｐ−１アゴニスト、インスリン及びメチオニンを含む薬学的組成物
CN102711804B (zh)	2009-11-13	2015-09-16	赛诺菲-安万特德国有限公司	包含glp-1激动剂和甲硫氨酸的药物组合物
CN101912600B (zh) *	2010-01-11	2014-01-29	杨国汉	改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) *	2010-05-12	2014-01-28	Biodel Inc.	Insulin with a stable basal release profile
AU2011202239C1 (en)	2010-05-19	2017-03-16	Sanofi	Long-acting formulations of insulins
CN103179978A (zh)	2010-08-30	2013-06-26	赛诺菲-安万特德国有限公司	Ave0010用于制造供治疗2型糖尿病用的药物的用途
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2013030160A1 (en)	2011-08-29	2013-03-07	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CA2870313A1 (en)	2012-04-11	2013-10-17	Novo Nordisk A/S	Insulin formulations
US9399065B2 (en)	2012-04-16	2016-07-26	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) *	2012-04-16	2016-07-05	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
SG11201506888VA (en)	2013-04-03	2015-09-29	Sanofi Sa	Treatment of diabetes mellitus by long-acting formulations of insulins
CN105636979B (zh)	2013-10-07	2020-01-10	诺和诺德股份有限公司	胰岛素类似物的新衍生物
MA41138B1 (fr)	2014-12-12	2023-07-31	Sanofi Aventis Deutschland	Formulation à rapport fixe d'insuline glargine/lixisenatide
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
US20180169190A1 (en)	2016-12-16	2018-06-21	Novo Nordisk A/S	Insulin containing pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2076082A (en) *	1935-04-08	1937-04-06	Nordisk Insulinlab	Therapeutic product and process
US2179384A (en) *	1937-04-05	1939-11-07	Univ Alberta	Therapeutic composition and process of making it
US2190134A (en) *	1939-06-09	1940-02-13	Norton Co	Grinding machine
US2538018A (en) *	1944-04-04	1951-01-16	Nordisk Insulinlab	Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) *	1945-01-03	1949-06-28	Rhone Poulenc Sa	Insulin preparations
US2801953A (en) *	1952-02-28	1957-08-06	Hoechst Ag	Process of preparing crystallized insulin preparations
US3102077A (en) *	1953-08-19	1963-08-27	Christensen Henry Marinus	Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) *	1959-06-16	1964-03-31	Henry Marinus Dr Christensen	Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) *	1971-04-30	1975-02-25	Lilly Co Eli	Protamine-insulin product
GB1426061A (en) *	1972-12-28	1976-02-25	Ici Ltd	Polypeptides
US3856771A (en) *	1973-07-16	1974-12-24	Lilly Co Eli	Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) *	1978-06-19	1980-04-01	Tiholiz Ivan C	Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) *	1981-03-10	1986-02-27	Novo Nordisk A/S	Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) *	1984-05-29	1989-06-13	Eli Lilly And Company	Stabilized insulin formulations
US4764592A (en) *	1987-04-23	1988-08-16	Eli Lilly And Company	Crystalline human proinsulin and process for its production

1987
- 1987-10-14 PH PH35937A patent/PH23446A/en unknown
- 1987-10-19 EP EP87309229A patent/EP0265213B1/en not_active Expired - Lifetime
- 1987-10-19 HU HU874683A patent/HU201475B/hu not_active IP Right Cessation
- 1987-10-19 IE IE279987A patent/IE60264B1/en not_active IP Right Cessation
- 1987-10-19 FI FI874596A patent/FI86254C/fi not_active IP Right Cessation
- 1987-10-19 NZ NZ222214A patent/NZ222214A/xx unknown
- 1987-10-19 PT PT85949A patent/PT85949B/pt unknown
- 1987-10-19 ES ES198787309229T patent/ES2033871T3/es not_active Expired - Lifetime
- 1987-10-19 IL IL84203A patent/IL84203A/xx not_active IP Right Cessation
- 1987-10-19 NO NO874347A patent/NO170754C/no unknown
- 1987-10-19 AU AU79907/87A patent/AU616381B2/en not_active Ceased
- 1987-10-19 YU YU191887A patent/YU46665B/sh unknown
- 1987-10-19 DE DE8787309229T patent/DE3778287D1/de not_active Expired - Lifetime
- 1987-10-20 CA CA000549713A patent/CA1316819C/en not_active Expired - Fee Related
- 1987-10-20 CN CN198787107049A patent/CN87107049A/zh not_active Withdrawn
- 1987-10-20 KR KR870011644A patent/KR880004819A/ko not_active Ceased
1989
- 1989-04-19 US US07/340,331 patent/US5070186A/en not_active Expired - Fee Related
1992
- 1992-06-11 GR GR920401262T patent/GR3004912T3/el unknown

Also Published As

Publication number	Publication date
GR3004912T3 (fi)	1993-04-28
HUT46232A (en)	1988-10-28
NZ222214A (en)	1989-11-28
NO170754B (no)	1992-08-24
YU191887A (en)	1989-04-30
PT85949A (en)	1987-11-01
FI86254C (fi)	1992-08-10
NO874347L (no)	1988-04-21
DE3778287D1 (de)	1992-05-21
KR880004819A (ko)	1988-06-27
PH23446A (en)	1989-08-07
US5070186A (en)	1991-12-03
FI86254B (fi)	1992-04-30
PT85949B (pt)	1990-07-31
FI874596A0 (fi)	1987-10-19
CN87107049A (zh)	1988-07-06
YU46665B (sh)	1994-01-20
EP0265213B1 (en)	1992-04-15
EP0265213A2 (en)	1988-04-27
AU616381B2 (en)	1991-10-31
IE872799L (en)	1988-04-20
CA1316819C (en)	1993-04-27
IE60264B1 (en)	1994-06-29
EP0265213A3 (en)	1988-11-09
NO170754C (no)	1992-12-02
AU7990787A (en)	1988-04-21
IL84203A (en)	1993-04-04
HU201475B (en)	1990-11-28
ES2033871T3 (es)	1993-04-01
NO874347D0 (no)	1987-10-19

Publication	Publication Date	Title
FI874596L (fi)	1988-04-21	Peptidpreparat.
FI874495L (fi)	1988-04-14	Peptidderivat.
FI873185A7 (fi)	1988-01-22	Uusia peptidejä.
FI873570L (fi)	1987-08-18	Peptidpreparat, foerfarande foer framstaellning av detta och anvaendning av detta.
FI860096L (fi)	1986-07-13	Haorfaergmedels-preparat.
DE3789413D1 (de)	1994-04-28	Lymphokin-ähnliche Peptide.
DE3774374D1 (de)	1991-12-12	Wundheilende zubereitungen.
NO881384L (no)	1988-10-03	Peptider.
NO890453D0 (no)	1989-02-03	Artropodicide preparater.
NO885108D0 (no)	1988-11-16	Peptider.
FI883257A7 (fi)	1988-07-07	Uudet peptidit.
DK354487A (da)	1988-01-12	Oncogen-relaterede peptider
FI874382A7 (fi)	1988-04-08	Farmaseuttiset valmisteet.
FI861193L (fi)	1986-09-26	Stabilt gammainterferonpreparat.
FI882921L (fi)	1988-06-17	Protaminzink-insulinpreparat.
NO875019D0 (no)	1987-12-02	Antikariogene preparater.
FI874587A0 (fi)	1987-10-19	Renande av protein.
FI864626L (fi)	1987-09-08	Rekombinantricintoxin.
FI881519L (fi)	1988-10-02	Schampopreparat.
DE3780388D1 (de)	1992-08-20	Fsh-stimulierendes peptid.
DK503386D0 (da)	1986-10-20	Peptidpraeparater
NO911243L (no)	1991-05-23	Kjemiske preparater.
DE3685636D1 (de)	1992-07-16	Lysozymbetreffende peptide.
NO872386D0 (no)	1987-06-05	Peptider.
FI875151A7 (fi)	1987-11-20	Uudet peptidijohdannaiset.

Legal Events

Date	Code	Title	Description
1996-05-17	MM	Patent lapsed
2004-08-31	MM	Patent lapsed	Owner name: NOVO NORDISK A/S